CA44432-5C - 0x00000000000065FA

Males & Females of Non-Childbearing Potential

Amaryllis

* Stipend may pay up to reflected amount.
Start Date: 
April 6, 2025 - 5:45am
End Date: 
April 14, 2025 - 8:00am

Study Details

Study Number: CA44432
Group Number: 5C
Study Requirement: Healthy Normal Male and Female
Stipend: up to $4,500.00

Study Criteria

Age: 18 - 55
BMI: 18 - 31
Weight Restriction: minimum weight 0 lbs

Study Information

Indication: This investigational medication is being developed for the treatment of Peripheral artery disease (PAD).
Route of Administration: Oral
Blood Draws: 21

Study Schedule

Schedule Type: Long Term
Study Length: 8 Night Stay

Screening Dates:

Event Day Event Date
Tuesday 3/25/2025

Doctor Exam Dates:

Event Day Event Date
Tuesday 3/25/2025

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Sunday 4/6/2025 5:45:00 AM Monday 4/14/2025 8:00:00 AM 1 Phoenix